Statistics for Arrowhead Pharmaceuticals (id:7444 ARWR)

Valuation metrics

Market cap

2.30B

Enterprise value

2.30B

Trailing P/E (ttm)

-9.69

Forward P/E

-4.39

PEG ratio

-4.39

Price/Sales (ttm)

117.30

Price/Book (mrq)

6.97

Enterprise Value/Revenue

117.09

Enterprise Value/EBITDA

-4.34

Overview

Shares outstanding

124.32M

Float

110.49M

Shares short

9.39M

% Held by insiders

0.04%

% Held by institutions

0.80%

Average volume (10 days)

1.08M

Average volume (90 days)

Price summary

52-Week low

17.05

52-Week high

39.83

52-Week change

-54.85%

Beta

0.93

50-Day moving average

19.92

200-Day moving average

24.64

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 17th, 2011

Financials

Fiscal year

Fiscal year ends

September 30th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,785.05%

Operational effectiveness

Return on assets

-40.72%

Return on equity

-151.84%

Income statement

Revenue (ttm)

0.17

Revenue per share (ttm)

0.17

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-529,777,984.00

Net income to common (ttm)

-538,636,032.00

Diluted EPS (ttm)

-4.65

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

434.47M

Total cash per share (mrq)

3.50

Total debt (mrq)

454.12M

Total Debt/Equity (mrq)

133.97

Current ratio (mrq)

465.40%

Book value per share (mrq)

2.66

Cash flow

Cash flow statement

-351,560,992.00

Levered free cash flow (LFCF)

-413,913,760.00